UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 564

Sortiert nach

Clinical Implications of Genomic Discoveries in Lung Cancer

The New England journal of medicine, 2016-05, Vol.374 (19), p.1864-1873

2016

Link zum Volltext

Verfügbarkeit prüfen

Overcoming Resistance to Targeted Therapy for Lung Cancer

The New England journal of medicine, 2015-04, Vol.372 (18), p.1760-1761

Govindan, Ramaswamy

2015

Link zum Volltext

Verfügbarkeit prüfen

Attack of the clones

Science (American Association for the Advancement of Science), 2014-10, Vol.346 (6206), p.169-170

Govindan, Ramaswamy

2014

Link zum Volltext

Verfügbarkeit prüfen

Genomic alterations in lung adenocarcinoma

The lancet oncology, 2015-07, Vol.16 (7), p.e342-e351

2015

Link zum Volltext

Verfügbarkeit prüfen

Lung Cancer in Never Smokers: A Review

Journal of clinical oncology, 2007-02, Vol.25 (5), p.561-570

2007

Link zum Volltext

Verfügbarkeit prüfen

Sotorasib for Lung Cancers with KRAS p.G12C Mutation

The New England journal of medicine, 2021-06, Vol.384 (25), p.2371-2381

2021

Link zum Volltext

Verfügbarkeit prüfen

Sex and gender: modifiers of health, disease, and medicine

The Lancet (British edition), 2020-08, Vol.396 (10250), p.565-582

2020

Link zum Volltext

Verfügbarkeit prüfen

Untangling the evolutionary roots of lung cancer

Nature communications, 2019-07, Vol.10 (1), p.2979-3, Article 2979

2019

Link zum Volltext

Verfügbarkeit prüfen

Lung cancer in never smokers: a new hot area of research

The lancet oncology, 2010-04, Vol.11 (4), p.304-305

Govindan, Ramaswamy

2010

Link zum Volltext

Verfügbarkeit prüfen

Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study

Journal of clinical oncology, 2016-03, Vol.34 (7), p.661-668

2016

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451

Journal of clinical oncology, 2021-04, Vol.39 (12), p.1349-1359

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecular genetics of lung cancer in people who have never smoked

The lancet oncology, 2008-07, Vol.9 (7), p.676-682

2008

Link zum Volltext

Verfügbarkeit prüfen

Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2018-10, Vol.36 (30), p.2995-3006

2018

Link zum Volltext

Verfügbarkeit prüfen

Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results Database

Journal of clinical oncology, 2006-10, Vol.24 (28), p.4539-4544

2006

Link zum Volltext

Verfügbarkeit prüfen

The oligometastatic state - separating truth from wishful thinking

Nature reviews. Clinical oncology, 2014-09, Vol.11 (9), p.549-557

2014

Link zum Volltext

Verfügbarkeit prüfen

INTERESTing biomarker to select IDEAL patients for epidermal growth factor receptor tyrosine kinase inhibitors: yes, for EGFR mutation analysis, others, I PASS

Journal of clinical oncology, 2010-02, Vol.28 (5), p.713-715

Govindan, Ramaswamy

2010

Link zum Volltext

Verfügbarkeit prüfen

Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline

Journal of clinical oncology, 2015-06, Vol.33 (18), p.2100-2105

2015

Link zum Volltext

Verfügbarkeit prüfen

Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers

Cell, 2012-09, Vol.150 (6), p.1121-1134

2012

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2013-11, Vol.31 (32), p.4105-4114

2013

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Study of Pemetrexed, Carboplatin, and Thoracic Radiation With or Without Cetuximab in Patients With Locally Advanced Unresectable Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 30407

Journal of clinical oncology, 2011-08, Vol.29 (23), p.3120-3125

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 564

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(533)
Mit Volltextzugriff
(518)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(293)
Humans
(290)
Life Sciences & Biomedicine
(277)
Oncology
(244)
Male
(142)
Female
(139)
Lung Neoplasms - Drug Therapy
(126)
Aged
(115)
Middle Aged
(114)
Lung Neoplasms - Pathology
(110)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(94)
Respiratory System
(93)
Adult
(87)
Lung Cancer
(76)
Carcinoma, Non-Small-Cell Lung - Pathology
(71)
Neoplasm Staging
(69)
Aged, 80 And Over
(64)
Lung Neoplasms - Genetics
(64)
Treatment Outcome
(54)
Lung Neoplasms - Therapy
(52)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Thoracic Oncology
(120)
Journal Of Clinical Oncology
(114)
Cancer Research
(30)
Clinical Lung Cancer
(20)
Lung Cancer
(17)
Clinical Cancer Research
(16)
Journal Of The National Comprehensive Cancer Network
(15)
Oncology Times
(11)
Oncology
(10)
The Lancet Oncology
(10)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Clinical Implications of Genomic Discoveries in Lung Cancer

Overcoming Resistance to Targeted Therapy for Lung Cancer

Attack of the clones

Genomic alterations in lung adenocarcinoma

Lung Cancer in Never Smokers: A Review

Sotorasib for Lung Cancers with KRAS p.G12C Mutation

Sex and gender: modifiers of health, disease, and medicine

Untangling the evolutionary roots of lung cancer

Lung cancer in never smokers: a new hot area of research

Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study

Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study

Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas

PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer

Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451

Molecular genetics of lung cancer in people who have never smoked

Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer

Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results Database

Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study

The oligometastatic state - separating truth from wishful thinking

INTERESTing biomarker to select IDEAL patients for epidermal growth factor receptor tyrosine kinase inhibitors: yes, for EGFR mutation analysis, others, I PASS

Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline

Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers

Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

Randomized Phase II Study of Pemetrexed, Carboplatin, and Thoracic Radiation With or Without Cetuximab in Patients With Locally Advanced Unresectable Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 30407

PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer

Suchergebnisse filtern